Objective: To understand neonatologists' attitudes toward end-of-life (EOL) management in clinical scenarios, EOL ethical concepts and resource utilization.
Introduction
The American Academy of Pediatrics (AAP) has published guidelines regarding limitation of life-sustaining treatments (LSTs) for critically ill children, [1] [2] [3] [4] [5] [6] and ethicists and legal experts have examined these issues. [7] [8] [9] Several studies explore physicians' end-of-life (EOL) decision-making in pediatric intensive care units and in adult critical care settings. [10] [11] [12] However, an extensive review of the literature finds no similar studies of US neonatologists and finds only a few EOL surveys of neonatology outside the US. Little is known about neonatologists' views on limiting care outside of the delivery room, as most research focuses on managing the extremely premature or severely affected infant immediately after birth. This study tries to understand American neonatologists' views regarding limiting LSTs in their most critically ill neonatal intensive care unit (NICU) patients.
Methods

Recruitment and survey distribution
After our survey was piloted among 12 neonatologists in the authors' institutions, it was approved by the Institutional Review Board of NorthShore University HealthSystem (granted 'exempt' status, which did not require a consent form because the data was collected anonymously) and by the AAP research department. An e-mail invitation with a link to the online survey was sent to all members of the AAP Perinatal section e-mail list. The e-mail was directed to neonatology attending physicians. The e-mail invitation included a brief review of literature on EOL care attitudes and clearly stated that voluntary participation would assist in the research goal of ascertaining 'actual practice and opinion of US practitioners.' The online survey tool Surveymonkey.com (R Finley, Portland, OR, USA) was used. Respondents' anonymity was assured; every respondent accessed the survey via one common internet address; internet addresses of the respondents' computers were not traced. Respondents were given 2 weeks to complete the survey; an e-mail reminder was sent after the first week.
Areas of interest
The survey was divided into three sections: clinical scenarios, attitudes toward general ethical concepts and personal data. First, respondents were presented four separate clinical scenarios (Table 1) . Respondents indicated their preferences in limiting LSTs in preparation for an upcoming family meeting. Scenarios A and B portrayed dying infants on full support in the NICU, and treatment options covered the spectrum of non-escalation of care, activating a do-not-resuscitate order, and discontinuing mechanical ventilation (MV), artificial nutrition or hydration (ANH) and vasopressors. Scenarios C and D represented infants who had conditions considered either lethal or resulting in extremely poor quality of life (QOL). The treatment options were similar except that discontinuation of artificial enteral feedings replaced vasopressors and transfer to hospice was added. Respondents chose one of five preferred actions for each management option; actions ranged from 'refuse' to 'strongly recommend.' Second, using a 5-point Likert scale, respondents rated their agreement with seven general ethical concepts (Table 1) , as well as their comfort with each of their responses. Finally, respondents indicated resources used in past difficult clinical cases and answered questions regarding nonidentifying demographic information. Two optional free-text questions provided opportunities to explain previous answers.
Data analysis
Data were collected and descriptive statistics were generated using Surveymonkey.com. Demographics were analyzed with respect to agree ('agree'/'strongly agree') and disagree ('disagree'/'strongly disagree') response groups for ethical concepts. The following statistical analyses were performed using SAS 9. 
Results
A total of 451 surveys were analyzed; eight additional surveys were excluded because of incomplete mandatory question sections. On the basis of an AAP-estimated 2700 neonatologists on the Perinatal section e-mail list, the survey response rate was about 17%. (AAP Perinatal section reports typical e-mail list survey response rate as 10 to 15%.) Table 2 displays responses for limiting LSTs in the four clinical scenarios. In all four scenarios, a majority of neonatologists were in agreement with, and even strongly recommended, nonescalation of care, do-not-resuscitate and withdrawal of MV; <10% of physicians refused these options. In the actively dying patients, withdrawal of vasopressors was offered or recommended. In the lethal or poor QOL patients, a majority recommended transfer to hospice. In all scenarios, up to one-third of neonatologists refused to withdraw ANH (i.v. or enteral). Of those that would withdraw ANH, agreeing to a family's request was more frequently chosen than offering or strongly recommending the option in most scenarios. In scenarios C and D in which limitation of enteral tube feedings was an option, refusing to discontinue enteral tube Increasing sedatives or narcotics to alleviate discomfort at the end of life are acceptable, even if this may hasten death.
Clinical scenarios
Concept 7
Withdrawing ventilator support on a dying infant who has received paralytics is acceptable.
Abbreviations: EEG, electroencephalography; GBS sepsis, group B streptococcal sepsis; MRI, magnetic resonance imaging; MV, mechanical ventilation; TPN, total parental nutrition.
Life-sustaining treatments: neonatologists' views DM Feltman et al feedings was more frequent than refusing to withdraw i.v. fluids. Limitations of LSTs were generally recommended more often for the patients in Scenarios C and D who were not actively dying, but had lethal conditions or extremely poor QOL. The only treatment options for which refusal was more frequent than agreement to parental wishes concerned ANH. The response to 'defer care' remained infrequent (0 to 6%) across scenarios. Figure 1 shows Likert scale distributions for agreement with ethical concepts and comfort with each response.
Ethical concepts
Level of agreement. The concepts of withdrawing MV or vasopressors and providing pain control proved largely noncontroversial among the neonatologists (<1 to 3% disagreed). The concept concerning withdrawing MV while on paralytics was the only statement with which more respondents disagreed (46.8%) than agreed (41.9%). Approximately one-third of respondents indicated some level of disagreement with ANH withdrawal and with equivalence of non-initiating versus withdrawing treatment.
Level of comfort. Comfort with response to an ethical concept question correlated with agreement with that concept.
Neonatologists reported the highest rates (14 to 20%) of being uncomfortable with their responses to questions about withdrawal of MV while on paralytics and of ANH. Demographics Respondents' demographic data are shown in Table 4 . About 60% of respondents were men; about half reported having >20 years of practice in neonatology. Nearly 95% practiced in level 3 NICUs; about 70% reported rotating residents and fellows. Religion responses from most to least frequent were Christian (non-Roman Catholic), Roman Catholic, none identified and Jewish. Neonatologists reported some (38%) and no (34%) influence of religion on responses.
Resource utilization
Analysis of response relationships
Multivariable analysis determined whether demographics contributed to differences in the four ethical concepts with the most controversy (concepts 1, 4, 5 and 7). Practicing in a level 3 NICU correlated to agreement with concept 1 (equivalence of withdrawing and withholding, P ¼ 0.01) and concept 5 (withdrawal of enteral tube feeds, P ¼ 0.02). More men agreed with concept 7 (MV withdrawal while on paralytics, P ¼ 0.002). Distributions of religions differed between agreement groups for the concepts concerning ANH (concept 4, total parental nutrition/i.v. hydration, P ¼ 0.0365 and concept 5, enteral tube feedings, P ¼ 0.0008). Although more Roman Catholics agreed than disagreed with concept 4 (71 vs 29%) and concept 5 (58 vs 42%), they were significantly less represented in the proportion of groups that agreed with these concepts. Jewish respondents were also significantly less represented in the group who agreed with concept 4. Those who agreed with the ANH withdrawal concepts reported significantly higher rates of religion as none identified than those who disagreed. No demographic differences were found between respondents who would or would not defer patient care to a colleague. Significant (P<0.0001) interconcept associations were 
Discussion
Withholding of LSTs across scenarios
Scenarios A and B depicted patients for whom death in the near future (hours to days) was very likely, whereas Scenarios C and D involved patients who could possibly live months to years with continued aggressive treatments. We were surprised that respondents reported higher rates of strongly recommending limitations of LSTs in the latter two scenarios in which QOL had a greater role than imminent death. Perhaps participants did not feel as strongly about recommending management changes for scenarios A and B because they felt these infants were doomed in the near future regardless of intervention decisions. Further examination of how physicians view treatment of infants with imminently terminal versus extremely poor QOL is warranted, as are investigations of attitudes toward patients with specific diagnoses, such as severe hypoxic-ischemic encephalopathy or lethal trisomy. These attitudes may change with time, as evidenced by a recent study, which examines neonatologists' willingness to provide delivery room resuscitation to a patient with trisomy 18 and cardiac anomaly.
13
Agreement with ethical concepts Non initiation versus withdrawal of therapy. The concept that not initiating treatment is ethically equivalent to withdrawing appears in multiple bioethics and medical association publications, including AAP guidelines. 1 However, one-third of our respondents did not agree with this statement. Higher rates of agreement were found in two surveys of PICU physicians in which about threequarters of respondents agreed that non-initiating is ethically the same as withdrawing a treatment. 10, 11 A study of ten European countries' neonatologists showed only about one-third to one-half agreed that withdrawing and withholding treatment are ethically equivalent.
14 Which action neonatologists regard as more ethically or emotionally challenging is not clear by the responses, and deserves further study. Neonatologists likely have more experience with not initiating treatments (particularly in the setting of the delivery room) in comparison with pediatric intensivists, although withdrawal of LSTs is the most common way infants in the NICU die. 15 Although the act of discontinuing treatment may feel more emotionally difficult for caregivers or parents than non-initiation, caregivers may find more comfort in withdrawing treatment after more information is known about the patient's condition, or after medical therapy has been maximized. 16 This perspective of at least giving the baby a chance was reflected in a few respondents' open answers.
Artificial nutrition and hydration. Withdrawal of ANH proved controversial. The four clinical scenarios were constructed to meet criteria enumerated in a recent AAP clinical report 3 and an ethics publication on the subject in which ANH withdrawal could be offered. 9 Similar to our results, Solomon et al. 10 reported that about one-third of PICU physicians and one-fourth of hematologists/oncologists would not discontinue ANH. A survey of internists by Asch and Christakis 12 examined physicians' reasons for preferring to limit some LSTs over others; many of our study's ' This is in contrast to the concept that pediatric palliative care literature explains; discontinuing ANH can actually alleviate suffering from edema and dyspnea in some dying patients. 17 The next most frequent response was the idea that artificial nutrition and hydration is 'basic,' not 'extraordinary' or 'heroic' care. Emotional difficulty for parents or other healthcare staff was reflected by several respondents.
Paralytics. This concept was most controversial in our study, and is the subject of discussion in recent literature. Wellesley and Jenkins 16 report the evolution of guidelines in the United Kingdom regarding paralytics and terminal gasping. Solomon et al. 10 do not support administering paralytic agents when discontinuing MV, as paralytics provide no pain relief, and interfere with adequate assessment and treatment of discomfort. They report that one-third of PICU physicians surveyed were uncertain or supported giving a paralytic agent before stopping the ventilator. We did not ask whether it is appropriate to give a paralytic agent in the face of discontinuing support. We agree that administration of paralytics does not provide pain control and therefore, does not promote the goals of palliative or comfort care. Rather, we asked whether it is acceptable to withdraw MV on a dying patient who is already receiving paralytics, as these medications are often used to prevent asynchrony with MV. Masking of pain signs by paralytics was a concern expressed in a few free-text responses in our study. Truog et al. 18 present convincing arguments for not administering paralytic agents, and in some cases waiting for neuromuscular activity to recover before withdrawing MV, while acknowledging that MV withdrawal on paralytics may be ethically justified in some cases.
Referring care. Nearly 20% of respondents replied to the general concept question (not linked to any specific scenario or medical therapy) that they would not defer patient care to a colleague to provide a parent-requested treatment with which they were uncomfortable. Curlin et al. 19 reported a similar refusal-to-refer rate of 18% in their cross-sectional survey of 2000 physicians across subspecialties. In their study, 'Physicians who were men, those who were religious and those who had personal objections to morally controversial clinical practices were less likely to report that doctors must disclose information about or refer patients for medical procedures to which the physician objected on moral grounds (multivariate odds ratios, 0.3 to 0.5).' Our study found no demographic or particular conceptual attitudes associated with the refusal to defer care.
Although further study is needed, claiming conscientious objection is a very likely explanation for why some physicians refuse to defer care. The challenge of balancing a physician's personal moral integrity and a patient's right to informed consent are addressed by a statement from the AAP's Committee on Bioethics. The publication warns, 'Permitting physicians, on the basis of a claim of conscience, not to disclose a legally available treatment option of which the patient is unaware but might otherwise choose would significantly undermine the practice of medicine.' 20 Without fully informed consent, the balance of physician-family decision-making is upset, shifting the decisionmaking to a more paternalistic dynamic in which the physician not offering a treatment may be trying to save the patient from doing something the physician thinks is wrong. Even if only a personal sense of conscience or culpability is driving decisions of disclosure or referral, the AAP explains, 'yphysicians' primary focus should be on their patients' rather than their own benefit. These role expectations are based in part on the power differential between physicians and patients, which is the result of physicians' knowledge and patients' conditions.' 20 Curlin et al. 19 recommend that patients be aware of these potential pitfalls in informed consent and treatmentF'Patients who want full disclosure from their own physicians might inform themselves of possible medical interventionsFa task that is not always easyFand might proactively question their physicians about these matters.' Although self-education and assertiveness may help these situations, justice, one of the four basic principles of bioethics, may be threatened if the onus is on patients and families to fully inform themselves. Those patients who are internet-savvy, well-educated, or have access to multiple opinions and providers will have a better chance of equal medical opportunities than families of lower income, less education and who are not native english speakers. As Lantos et al. 21 discuss in their report of a select physician group examining neonatal EOL cases, 'Variations in physicians' practice styles and moral values can lead to arbitrariness in available options for parents.'
Study limitations
Our response rate was higher than past online surveys using the AAP Perinatal e-mail list. Although distribution by mail or in person may have contributed to other published studies' higher rates, we chose an online tool to assure anonymity and to reach as many neonatologists over a wide geographic and practice-setting distribution as possible. Strong opinions regarding EOL issues held by some neonatologists may have contributed to selection bias, as could have targeting members of the AAP Perinatal section. Despite these limitations, overall sample size was adequate for statistical analyses, and responses showed a wide distribution of attitudes. Results of this study must be interpreted understanding that judgments based on theoretical clinical scenarios with few details may prompt different decisions than would the complex situations of actual patients.
Conclusion
This study demonstrates that many neonatologists agree on certain aspects of withdrawing LSTs for very ill patients, such as withdrawal of MV, and report being likely to recommend this practice. However, as in other medical subspecialties, many neonatologists view discontinuation of ANH as different from limiting other LSTs, regardless of clinical scenario. Much of our understanding about discontinuation of ANH comes from adult literature, and information regarding practical aspects of comfort care for this type of limitation in children is sparse. This area of neonatal EOL care deserves further attention to ensure a better understanding of the process, to foster dialog among clinicians, and to thereby present options at the end of life to parents in a cohesive manner.
One in five neonatologists in this survey said that they would not refer their patient to the care of a colleague in the face of a parental request for treatment with which they themselves were uncomfortable. Although care must be taken to preserve a physician's personal integrity, we must ensure that each patient is given as equal an experience in healthcare as possible. Further research in this area of bioethics and clinical practice, preemptive discussions about difficult issues amongst caregivers (that is, how to handle cases in which some are not comfortable), employment of resources like palliative care specialists, ethics committees, and consideration of pediatric-specific guidelines may help to achieve this goal. In our study, statements of the AAP's Fetus and Newborn Committee were accessed more frequently than those of other committees. Perhaps heightened awareness of other AAP committees' pertinent statements 1, 4, 5, 20 could promote strategies to address controversial ethical considerations, and encourage disclosure of treatment options to enable fully informed consent. A just, unified strategy will optimize care for patients and families in these most difficult situations.
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